The tweet was deleted by the author.
But we saved everything 🙂.
Eric Lefkofsky reported that his team presented 31 scientific abstracts at the 2026 American Association for Cancer Research (AACR26) meeting. These presentations centered on uncovering insights that could drive fundamental changes in the standard of care for patients. Lefkofsky noted that the session co-hosted with Bristol Myers Squibb at the Spotlight Theater drew a large audience, reflecting significant interest in advancing cancer treatment methodologies.